Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies

NCT01292460 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open-angle Glaucoma

Interventions

DRUG: Timolol/ FDC/ Placebo/ Tafluprost

Sponsor

Santen Oy